BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases
- PMID: 12370363
- DOI: 10.4049/jimmunol.169.8.4314
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases
Abstract
BLyS and APRIL are two members of the TNF superfamily that are secreted by activated myeloid cells and have costimulatory activity on B cells. BLyS and APRIL share two receptors, TACI and BCMA, whereas a third receptor, BAFF-R, specifically binds BLyS. Both BLyS and APRIL have been described as homotrimeric molecules, a feature common to members of the TNF superfamily. In this study, we show that APRIL and BLyS can form active heterotrimeric molecules when coexpressed and that circulating heterotrimers are present in serum samples from patients with systemic immune-based rheumatic diseases. These findings raise the possibility that active BLyS/APRIL heterotrimers may play a role in rheumatic and other autoimmune diseases and that other members of the TNF ligand superfamily may also form active soluble heterotrimers.
Similar articles
-
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.Arthritis Res Ther. 2010;12(2):R48. doi: 10.1186/ar2959. Epub 2010 Mar 19. Arthritis Res Ther. 2010. PMID: 20302641 Free PMC article.
-
Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.J Immunol. 2004 Mar 1;172(5):3268-79. doi: 10.4049/jimmunol.172.5.3268. J Immunol. 2004. PMID: 14978135
-
BLyS and APRIL in rheumatoid arthritis.J Clin Invest. 2005 Nov;115(11):3083-92. doi: 10.1172/JCI25265. Epub 2005 Oct 20. J Clin Invest. 2005. PMID: 16239971 Free PMC article.
-
Mechanism of BLyS action in B cell immunity.Cytokine Growth Factor Rev. 2002 Feb;13(1):19-25. doi: 10.1016/s1359-6101(01)00025-9. Cytokine Growth Factor Rev. 2002. PMID: 11750877 Review.
-
[B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis].Reumatismo. 2004 Jul-Sep;56(3):143-6. doi: 10.4081/reumatismo.2004.143. Reumatismo. 2004. PMID: 15470519 Review. Italian.
Cited by
-
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.Dig Dis Sci. 2016 Dec;61(12):3407-3424. doi: 10.1007/s10620-016-4317-9. Epub 2016 Sep 21. Dig Dis Sci. 2016. PMID: 27655102 Review.
-
Cytokines as therapeutic targets in SLE.Nat Rev Rheumatol. 2010 Jun;6(6):339-47. doi: 10.1038/nrrheum.2010.64. Epub 2010 May 4. Nat Rev Rheumatol. 2010. PMID: 20440285 Review.
-
Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures.Front Immunol. 2014 Jan 6;4:509. doi: 10.3389/fimmu.2013.00509. eCollection 2014 Jan 6. Front Immunol. 2014. PMID: 24432023 Free PMC article. Review.
-
Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies.ACR Open Rheumatol. 2023 Oct;5(10):536-546. doi: 10.1002/acr2.11594. Epub 2023 Sep 14. ACR Open Rheumatol. 2023. PMID: 37710418 Free PMC article.
-
Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.Sci Rep. 2022 Jul 2;12(1):11219. doi: 10.1038/s41598-022-15549-0. Sci Rep. 2022. PMID: 35780200 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
